C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms

Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
11/2002
11/21/2002	US20020173482 Antitumor, anticancer agents
11/20/2002	EP1258248A2 Tumor treatments comprising a fumagillol derivative and a further antineoplastic agent
11/20/2002	CN1380882A C10 ester substituted taxanes as antitumor agents
11/19/2002	US6482963 C9 hydrido, hydroxy and acyloxy taxane derivatives and pharmaceutical compositions containing them
11/19/2002	US6482850 Hydrolysis-promoting hydrophobic taxane derivatives
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/18/2002	CA2381829A1 A method for tumor treatment with fumagillol derivatives
11/13/2002	EP1255747A2 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
11/13/2002	EP1255745A2 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii
11/13/2002	EP1183250A4 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
11/12/2002	US6479679 Two-step conversion of protected taxane ester to paclitaxel
11/12/2002	US6479678 Metal alkoxide taxane and β-lactam compounds
11/12/2002	US6479623 Amorphous polyether glycols based on bis-substituted oxetane monomers
11/07/2002	US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier
11/06/2002	EP1254128A2 Production of taxol and taxanes
11/06/2002	CN1377882A Process for coproducing high purity taxol cephalomtanine, and 10-deacetyl Bakating III
11/05/2002	US6476242 2-aroyl-4-acyl paclitaxel (Taxol) analogs
10/2002
10/31/2002	WO2002085879A1 Three-step conversion of protected taxane ester to paclitaxel
10/31/2002	WO2002085878A1 Two-step conversion of protected taxane ester to paclitaxel
10/31/2002	US20020161238 Novel methods for the preparation of taxanes using oxazolidine intermediates
10/31/2002	US20020161135 Crosslinked polyorthoester
10/31/2002	CA2445250A1 Three-step conversion of protected taxane ester to paclitaxel
10/31/2002	CA2445042A1 Two-step conversion of protected taxane ester to paclitaxel
10/30/2002	EP1251846A1 C-4 carbonate taxanes
10/29/2002	CA2071979C Process for the preparation of cis-beta-phenylglycidic-(2r,3r)acid
10/24/2002	WO2002083180A1 Elongated and multiple spacers in activatible prodrugs
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002038556A3 Process for mass production of gmp paclitaxel and related taxanes
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/23/2002	EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/23/2002	EP0674630B1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/22/2002	US6469186 Extractions, separations, and purifications of taxus canadensis; anticancer agents
10/22/2002	US6469108 Cationically curable oxetanyl-containing naphthalene and aromatic epoxy or oxetane compound
10/22/2002	US6469050 7-hexanoyltaxol and methods for preparing the same
10/17/2002	US20020151579 Process for mass production of GMP paclitaxel and related taxanes
10/16/2002	EP1248776A1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities
10/15/2002	US6465625 Taxol derivatives
10/10/2002	WO2002078690A2 Taxoid anti-tumor agents and pharmaceutical compositions thereof
10/10/2002	US20020147335 Anticancer, antitumor agents
10/09/2002	EP0679082B1 C10 taxane derivatives and pharmaceutical compositions
10/08/2002	US6462208 C7 acyloxy and hydrido taxane derivatives and pharmaceutical compositions containing them
10/03/2002	WO2002076967A1 Process for making taxane derivatives
10/03/2002	WO2002076459A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002	WO2002076448A1 Molecular conjugates for use in treatment of cancer
10/03/2002	WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002	WO2002076402A2 Fatty amine drug conjugates
10/03/2002	US20020143048 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
10/03/2002	CA2441484A1 Molecular conjugates for use in treatment of cancer
10/03/2002	CA2439676A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/02/2002	EP0960107B1 6-thio-substituted paclitaxels
10/02/2002	EP0690853B1 Taxanes prepared by beta-lactams and ammonium alkoxides
10/02/2002	CN1372466A New use of docetaxel for treating hepatoma
10/01/2002	US6458977 Taxane derivatives as anticarcinogenic or antitumor agents
10/01/2002	US6458976 Taxane anticarcinogenic agents and antitumor agents
10/01/2002	US6458827 Adjustent of conformation equilibrium; active materials
09/2002
09/26/2002	WO2000068290A3 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof
09/26/2002	US20020137955 Reaction of an oxazole compound, (phenylisoserine derivative) with a hydroxyl-protected Baccatin III derivative to produce a taxane substrate that can be used to form paclitaxel and other taxanes
09/26/2002	US20020137927 Intermediates in the preparation of sidechain-bearing taxanes such as taxol and taxol derivatives.
09/25/2002	EP1243276A1 Elongated and multiple spacers containing activatible prodrugs
09/25/2002	EP1242401A1 Cytotoxic agents comprising taxanes and their therapeutic use
09/25/2002	CN1370773A Tubular chlorine alcoholating reactor without inner part and with chloride dissolved gradually
09/24/2002	US6455575 Phosphonooxymethyl ethers of taxane derivatives
09/19/2002	WO2002072527A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof
09/19/2002	WO2002072010A2 Taxane prodrugs
09/19/2002	US20020131965 Conjugate of a bioactive agent covalently attached to a transport polymer, having guanidino or amidino side chains, such as an arginine-containing polypeptide
09/19/2002	CA2441088A1 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof
09/19/2002	CA2440225A1 Taxane prodrugs
09/18/2002	CN1369484A Process for separating and purifying ebormycine from fermented myxobacterium liquid
09/18/2002	CN1091105C Method for separation and purification of taxol and taxane
09/17/2002	US6452025 Three-step conversion of protected taxane ester to paclitaxel
09/17/2002	US6452024 Process for extraction and purification of paclitaxel from natural sources
09/12/2002	WO2002070498A1 Methods for preparing new taxoids and pharmaceutical compositions containing them
09/12/2002	US20020128498 Semi-synthesis of a protected baccatin III compound
09/12/2002	CA2438829A1 Methods for preparing new taxoids and pharmaceutical compositions containing them
09/11/2002	EP0912504B1 Oxazolidine ester
09/11/2002	CN1090625C Method for selective protection of baccation derivatives and its application to taxane synthesis
09/10/2002	US6448417 Esterification of c-7, c-10 di-cbz 10-deacetylbaccatin iii with an n-carbamate protected, c-2-protected 3-phenyl isoserine side chain
09/10/2002	US6448368 Hydroxy terminated polyethers having asymmetric pendant alkoxymethylene groups; hydrophobic; preparation of polyurethane elastomers, thermoset plastics and coatings
09/06/2002	WO2002067928A2 Metronomic dosing of taxanes for inhibiting tumor growth
09/06/2002	CA2439299A1 Metronomic dosing of taxanes
09/04/2002	EP1056736B1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position
09/03/2002	US6444825 Chemical intermediate for taxol
08/2002
08/29/2002	US20020119202 For therapy of cancer and other angiogenic-dependent diseases
08/28/2002	EP0769064B1 A method for mass production of taxol by semi-continuous culture
08/28/2002	CN1089761C Sidechain-bearing texanes and its preparing process
08/27/2002	US6441253 Method for the synthesis of taxanes
08/21/2002	EP0668862B1 Oxidation of glycoside substituted taxanes to taxol or taxol precursors and taxane compounds formed as intermediates
08/20/2002	US6437154 From 7-xylosyl-10-deacetylbaccatin taxol derivatives, dissolving in a polar solvent, reacting with a base, and then with a periodate tocleave the diol system of the xyloside into a dialdehyde, reacting with amine salt
08/20/2002	US6436931 Cytotoxic agents comprising taxanes and their therapeutic use
08/15/2002	WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses
08/15/2002	US20020110873 Process for the production of lipstatin and tetrahydrolipstatin
08/14/2002	EP0941219B1 Intermediate for use in docetaxel synthesis and production method therefor
08/13/2002	US6433189 Tricyclic and tetracyclic taxane intermediates
08/13/2002	US6433180 Carboxylic acids for synthesis of taxane derivatives
08/13/2002	US6432928 Complexes and their compositions
08/13/2002	CA2212357C 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them
08/08/2002	US20020107409 Halogenated paclitaxel derivatives
08/07/2002	EP1229030A2 Hydrolysis-promoting taxane hydrophobic derivates
08/07/2002	EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain
08/07/2002	CN2504272Y 氯醇化反应器 Chlorohydrination reactor

1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 55